Detalhe da pesquisa
1.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Immunity
; 53(1): 98-105.e5, 2020 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32561270
2.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Cell Rep
; 36(2): 109353, 2021 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34237283
3.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects.
bioRxiv
; 2021 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33791692
4.
Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus.
Cell Rep Med
; 1(3)2020 06 23.
Artigo
Inglês
| MEDLINE | ID: mdl-32724901
5.
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
bioRxiv
; 2020 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32511342